ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,180Medicare Part D Prescriptions Filled, Including Refills

Rank: 97 out of 973

$528K Total Retail Price of All Prescriptions

Rank: 126 out of 973

473 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 473 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 473 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 8,590 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LISINOPRIL 499 405 1 3
HYDROCODONE-ACETAMINOPHEN 467 246 S3 2 4
SIMVASTATIN 452 371 3 1
LEVOTHYROXINE SODIUM 443 368 4 2
FUROSEMIDE 371 313 5 6
OMEPRAZOLE 352 294 6 5
WARFARIN SODIUM 344 326 7 10
METOPROLOL TARTRATE 280 250 8 13
POTASSIUM CHLORIDE 279 252 9 9
ATENOLOL 217 187 10 16
METOPROLOL SUCCINATE 208 192 11 17
METFORMIN HCL 203 164 12 8
ZOLPIDEM TARTRATE 186 142 13 20
HYDROCHLOROTHIAZIDE 180 159 14 11
AMLODIPINE BESYLATE 176 151 15 7
CITALOPRAM HBR 175 158 16 14
SERTRALINE HCL 163 121 17 21
DIGOXIN 145 114 18 32
ALENDRONATE SODIUM 143 139 19 24
LOVASTATIN 129 110 20 38
ALLOPURINOL 126 123 21 29
OXYBUTYNIN CHLORIDE 114 94 22 92
GLYBURIDE 108 84 R 23 59
ENDOCET 97 23 S2 24 169
CYCLOBENZAPRINE HCL 96 32 R 25 42
ATORVASTATIN CALCIUM 93 72 26 15
PROPRANOLOL HCL 84 51 27 97
ACETAMINOPHEN-CODEINE 79 77 S3 28 134
LANTUS 76 61 29 39
NEXIUM 76 37 29 30
LOSARTAN POTASSIUM 75 64 31 19
GABAPENTIN 74 60 32 12
PRAVASTATIN SODIUM 70 68 33 22
PROAIR HFA 69 43 34 54
METHADONE HCL 67 0 S2 35 129
CARVEDILOL 63 31 36 27
DIOVAN 62 62 37 63
NOVOLOG 61 49 38 82
OXYCONTIN 60 0 S2 39 126
GEMFIBROZIL 60 44 39 83
LOSARTAN-HYDROCHLOROTHIAZIDE 58 57 41 46
FLUTICASONE PROPIONATE 57 47 42 35
AZITHROMYCIN 57 36 42 47
ISOSORBIDE MONONITRATE 57 57 42 300
LEVOFLOXACIN 56 47 45 84
FENTANYL 56 28 S2 45 53
DONEPEZIL HCL 55 42 47 26
JANUVIA 53 45 48 88
TRAMADOL HCL 53 21 48 18
FLUOXETINE HCL 52 41 50 56
METOLAZONE 52 52 50 170
CLOPIDOGREL 51 46 52 44
DILTIAZEM ER 51 25 52 109
PREDNISONE 51 46 52 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.